Joshua LeClaire, MD

Education & Training:
2017-2018 Hematopathology Fellowship, Department of Pathology,
University of Nebraska Medical Center, Omaha, NE
2009 Cytopathology Fellowship, MetroHealth Medical Center –
Case Western Reserve University, Cleveland, OH
2008 Anatomic and Clinical Pathology Residency, Summa Health System –
Akron City Hospital Akron, OH
2004 Doctor of Osteopathy, Ohio University College of Osteopathic Medicine, Athens, OH
2000 Master of Science, Pathologists’ Assistant Program,
The Ohio State University, Columbus, OH
1997 Bachelor of Arts: Biology, Chemistry Minor, University of Minnesota - Duluth, Duluth, MN
1997 Bachelor of Arts and Science: Life Science Education,
University of Minnesota - Duluth, Duluth, MN

Presentations, Publications, Poster Sessions:

Waldman WJ, LeClaire JD, Knight DA, “T cell activation response to allogeneic CMV infected endothelial cells is not prevented by ganciclovir or foscarnet: Implications for transplant vascular sclerosis.” Transplantation, Vol: 73, 314-318

Waldman WJ, LeClaire JD, Knight DA, “Attenuation of macrophage-mediated antigen-specific T lymphocyte activation by actual and synthetic airborne particulates.” Experimental Biology 2002 (American Society of Investigative Pathology), New Orleans, LA, 2002

Waldman WJ, LeClaire JD, Knight DA, “Impact of Antiviral Agents upon the inflammatory potential of CMV-infected endothelial cells.” Eighth International Cytomegalovirus Conference, Monterey, CA, 2001

LeClaire JD, Yandila R, “Parvovirus B19 infection as a Cause of Anemia in an Immunosuppressed HIV-infected Patient.” 2006 Post-Graduate Day (poster presentation), Summa Health System, Akron, OH